Biotech News

Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance

Integra LifeSciences (IART)Integra LifeSciences2026-06-25 13:46 ESTEarnings

PRINCETON, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Reported revenues were $434.9 million, representing a decrease of 1.7% on

Open original release

Related news

IARTIntegra LifeSciences2026-06-25 13:46 EST

Integra LifeSciences Announces Key Executive Appointments

IARTIntegra LifeSciences2026-06-25 13:46 EST

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

IARTIntegra LifeSciences2026-06-25 13:46 EST

Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference

IARTIntegra LifeSciences2026-06-25 13:46 EST

Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference

IARTIntegra LifeSciences2026-06-25 13:46 EST

Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access

IARTIntegra LifeSciences2026-06-25 13:46 EST

Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference

IARTIntegra LifeSciences2026-06-25 13:46 EST

Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference

IARTIntegra LifeSciences2026-06-25 13:46 EST

Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026

IARTIntegra LifeSciences2026-06-25 13:46 EST

Integra LifeSciences Announces Key Executive Leadership Appointments

IARTIntegra LifeSciences2026-06-25 13:46 EST

Integra LifeSciences Unveils New Real-World Evidence Highlighting PriMatrix® Utilization

View all latest news

Integra LifeSciences

Integra LifeSciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

IARTIntegra LifeSciences2026-06-26 12:03 EST

Integra LifeSciences Announces Key Executive Appointments

IARTIntegra LifeSciences2026-06-26 12:03 EST

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

IARTIntegra LifeSciences2026-06-26 12:03 EST

Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference

IARTIntegra LifeSciences2026-06-26 12:03 EST

Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference

IARTIntegra LifeSciences2026-06-26 12:03 EST

Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States